Italy’s biotech lobby sets a 2036 roadmap to boost national scientific and industrial capacity
Executive summary: Assobiotec launched its Horizon 2036 manifesto outlining requirements for Italy to fully leverage its scientific, industrial and social potential by 2036. The manifesto establishes a policy agenda that could shape biotech investment, R&D funding and regulatory frameworks in Italy.
Who is involved: Assobiotec (Federchimica) and Italian government stakeholders, with implications for investors and research institutions.
Likely next: Discussion among policymakers and industry on implementation measures, including possible funding programs and regulatory adjustments.
Assobiotec, the Italian association of chemical and biotech firms, published a strategic manifesto titled Horizon 2036 that defines the conditions for Italy to fully exploit its scientific, industrial and social potential by 2036. The document calls for clearer regulatory frameworks, targeted R&D funding and strengthened public‑private collaboration. It signals a long‑term policy agenda that could reshape the biotech landscape in Italy and influence related investment decisions.
Timeline
- — Assobiotec lancia il manifesto Orizzonte 2036 (Il Sole 24 Ore — Economia)
Analysis — what this means
Likely next events
- Government releases implementation guide for Horizon 2036 measures
- Industry associations publish position papers on funding priorities
- Potential legislative proposals to support biotech R&D
Sectors affected
- Biotechnology
- Pharmaceuticals
- R&D Services
Regulatory implications
- Incentives for private R&D investment
- Clarification of public funding eligibility criteria
Key entities
Sources
- Assobiotec lancia il manifesto Orizzonte 2036 — Il Sole 24 Ore — Economia